DLSOM: A Deep learning-based strategy for liver cancer subtyping
Liver cancer is a leading cause of cancer-related mortality worldwide, with its high genetic heterogeneity complicating diagnosis and treatment. This study introduces DLSOM, a deep learning framework utilizing stacked autoencoders to analyze the complete somatic mutation landscape of 1,139 liver cancer samples, covering 20,356 protein-coding genes. By transforming high-dimensional mutation data into three low-dimensional features, DLSOM enables robust clustering and identifies five distinct liver cancer subtypes with unique mutational, functional, and biological profiles. Subtypes SC1 and SC2 exhibit higher mutational loads, while SC3 has the lowest, reflecting mutational heterogeneity. Novel and COSMIC-associated mutational signatures reveal subtype-specific molecular mechanisms, including links to hypermutation and chemotherapy resistance. Functional analyses further highlight the biological relevance of each subtype. This comprehensive framework advances precision medicine in liver cancer by enabling the development of subtype-specific diagnostics, biomarkers, and therapies, showcasing the potential of deep learning in addressing cancer complexity.
Code (0)
등록된 구현이 없습니다.
Tasks
Deep LearningSimilar Papers 제목 키워드 기반
A Hierarchical Geometry-guided Transformer for Histological Subtyping of Primary Liver Cancer
Primary liver malignancies are widely recognized as the most heterogeneous and prognostically diverse cancers of the digestive system. Among these, hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC)…
Boosting Pathology Foundation Models via Few-shot Prompt-tuning for Rare Cancer Subtyping
Rare cancers comprise 20-25% of all malignancies but face major diagnostic challenges due to limited expert availability-especially in pediatric oncology, where they represent over 70% of cases. While pathology vision-la…
Scalable and Loosely-Coupled Multimodal Deep Learning for Breast Cancer Subtyping
Healthcare applications are inherently multimodal, benefiting greatly from the integration of diverse data sources. However, the modalities available in clinical settings can vary across different locations and patients.…
Multimodal Deep LearningDeep learning-based classification of breast cancer molecular subtypes from H&E whole-slide images
Classifying breast cancer molecular subtypes is crucial for tailoring treatment strategies. While immunohistochemistry (IHC) and gene expression profiling are standard methods for molecular subtyping, IHC can be subjecti…
whole slide imagesSubtype-Former: a deep learning approach for cancer subtype discovery with multi-omics data
Motivation: Cancer is heterogeneous, affecting the precise approach to personalized treatment. Accurate subtyping can lead to better survival rates for cancer patients. High-throughput technologies provide multiple omics…
Survival Analysis